PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-06-01

Date Title Company
01-Jun-2021 Lengo Therapeutics Appoints Diana Hausman as Chief Medical Officer Businesswire
01-Jun-2021 Sesen Bio Strengthens Senior Leadership Team Businesswire
01-Jun-2021 Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis Amgen and Kyowa Kirin
01-Jun-2021 Sanofi provides update on venglustat clinical program Sanofi
01-Jun-2021 Moderna Announces Initiation of Rolling Submission of Biologics License Application (BLA) with U.S. FDA for the Moderna COVID-19 Vaccine Businesswire
01-Jun-2021 NexTech AR Solutions Announces Appointment of New CFO Businesswire
01-Jun-2021 Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of Renuvion® in Dermal Resurfacing Procedures Businesswire
01-Jun-2021 Mycovia Pharmaceuticals Submits New Drug Application to the U.S. FDA for Oteseconazole for the Treatment of Recurrent Vulvovaginal Candidiasis Businesswire
01-Jun-2021 NHS treats first patient with the ‘world’s most expensive drug’ NHS England
01-Jun-2021 Personnel changes at Merck Group level to further push science & technology based strategic growth trajectory Merck Group
01-Jun-2021 Excalibur Launches New Covid-19 ‘Test to Go’ App for Work, Leisure and Travel Businesswire
01-Jun-2021 CDISC Teams Up with Microsoft to Develop Open-Source Software for the Clinical Research Community Businesswire
01-Jun-2021 COREX Logistics opens Kazakhstan office COREX Logistics
01-Jun-2021 Cardiovascular Systems, Inc. Announces U.S. Commercial Launch of JADE Over-the-Wire Non-Compliant Peripheral Balloon Catheters Businesswire
01-Jun-2021  Precision BioSciences Announces New Study Published in Nature Communications Using Engineered ARCUS Nuclease to Target Mutant Mitochondrial DNA In Vivo Businesswire
01-Jun-2021 Cybin Announces Sponsorship of a Kernel Flow Feasibility Study to Measure Ketamine’s Psychedelic Effects on Cerebral Cortex Hemodynamics Businesswire
01-Jun-2021 BridgeBio Pharma’s Affiliate QED Therapeutics and Partner Helsinn Group Announce FDA Approval of TRUSELTIQ™ (infigratinib) for Patients with Cholangiocarcinoma Businesswire
01-Jun-2021 Merck and Sanofi’s First and Only Six-in-One Pediatric Combination Vaccine Now Available in the United States Businesswire
01-Jun-2021 Infectious Disease Diagnostics Market : Rising technological advancements in infectious disease diagnostics markets and markets
01-Jun-2021 Lineage Cell Therapeutics Reports Additional Cases of Retinal Tissue Restoration in Dry AMD Patients Treated With OpRegen® RPE Cells Businesswire